State of Wisconsin Investment Board’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,981
Closed -$22.5K 2494
2025
Q4
$22.5K Sell
13,981
-178,467
-93% -$374K ﹤0.01% 2354
2025
Q3
$525K Buy
+192,448
New +$640K ﹤0.01% 1868
2021
Q4
Sell
-185,734
Closed -$535K 2150
2021
Q3
$535K Hold
185,734
﹤0.01% 1676
2021
Q2
$704K Hold
185,734
﹤0.01% 1578
2021
Q1
$629K Hold
185,734
﹤0.01% 1507
2020
Q4
$520K Sell
185,734
-23,100
-11% -$67.4K ﹤0.01% 1524
2020
Q3
$524K Sell
208,834
-6,500
-3% -$57K ﹤0.01% 1469
2020
Q2
$2.92M Buy
215,334
+33,100
+18% +$342K 0.01% 1040
2020
Q1
$1.38M Sell
182,234
-94,066
-34% -$732K ﹤0.01% 1143
2019
Q4
$1.75M Sell
276,300
-4,200
-1% -$20K ﹤0.01% 1152
2019
Q3
$1.1M Buy
280,500
+58,700
+26% +$252K ﹤0.01% 1117
2019
Q2
$1.07M Buy
221,800
+2,599
+1% +$14.8K ﹤0.01% 1120
2019
Q1
$1.79M Buy
219,201
+26,400
+14% +$181K 0.01% 1030
2018
Q4
$1.07M Buy
192,801
+36,535
+23% +$286K ﹤0.01% 1111
2018
Q3
$1.38M Buy
156,266
+130,266
+501% +$1.17M ﹤0.01% 1111
2018
Q2
$259K Hold
26,000
﹤0.01% 1406
2018
Q1
$248K Hold
26,000
﹤0.01% 1386
2017
Q4
$387K Hold
26,000
﹤0.01% 1324
2017
Q3
$511K Hold
26,000
﹤0.01% 1290
2017
Q2
$374K Buy
+26,000
New +$330K ﹤0.01% 1345

Other funds holding AKBA

State of Wisconsin Investment Board's AKBA Position: Q1 2026 in Review

State of Wisconsin Investment Board sold out of Akebia Therapeutics (AKBA) in Q1 2026, closing a stake of 13,981 shares — an estimated $22.5K sold.

State of Wisconsin Investment Board first reported a position in AKBA in Q2 2017 and held it in 20 quarters. The position peaked at $2.92M in Q2 2020. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • State of Wisconsin Investment Board reported no remaining Akebia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 13,981 Akebia Therapeutics shares in Q1 2026, an estimated $22.5K.
  • State of Wisconsin Investment Board first reported a position in Akebia Therapeutics in Q2 2017 and held it in 20 quarters.
  • State of Wisconsin Investment Board's Akebia Therapeutics position peaked at $2.92M in Q2 2020.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.